Generate a tailored SOP for Dr. Miguel De Mulder Rougvie. Improve your application with a focused, well-structured draft.
Miguel de Mulder Rougvie is an Adjunct Assistant Professor in the field of Genetic Medicine. His research primarily centers on various aspects of gene therapy and its implications for treating genetic and infectious diseases. He has conducted significant studies on the involvement of human endogenous retroviruses in conditions such as systemic lupus erythematosus and various cancers, especially focusing on their role as potential biomarkers or therapeutic targets. De Mulder Rougvie has co-authored multiple publications, contributing to the understanding of HIV latency, effects of gene therapy, and the role of immune mediators in HIV acquisition. His work aims to enhance the efficacy of antiviral therapies and improve patient outcomes in genetic medicine.
Cornell University • Ithaca, NY
Teaching and conducting research in the area of Genetic Medicine, focusing on gene therapy and viral interactions.
Department of Architecture